PatientsVille.com Logo

PatientsVille

Kenacort Side Effects

Common Kenacort Side Effects

The most commonly reported Kenacort side effects (click to view or check a box to report):

Scleral Thinning (8)
Endophthalmitis (8)
Cytomegalovirus Chorioretinitis (8)
Retinal Artery Occlusion (7)
Retinal Detachment (6)
Glaucoma (5)
Adverse Event (5)
Anaphylactic Reaction (5)
Retinal Pigment Epitheliopathy (5)
Muscle Atrophy (5)
Intraocular Pressure Increased (5)
Atrophy (4)
Anaphylactic Shock (4)
Conjunctival Haemorrhage (4)
Anaphylactoid Reaction (4)
Injection Site Atrophy (4)
Paraesthesia (4)
Pain (4)
Haemarthrosis (4)
Necrotising Scleritis (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Kenacort Side Effects Reported to FDA

The following Kenacort reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Kenacort on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Petit Mal Epilepsy
on Mar 05, 2014 Female from NL , 75 years of age, was diagnosed with and was treated with Kenacort-a40 Inj 40 Mg. Directly after, patient experienced the unwanted or unexpected Kenacort side effects: petit mal epilepsy. Kenacort-a40 Inj 40 Mg dosage: N/A.
Associated medications used:
  • Teriparatide (1 Df=20 Mcg/ml Inj Fluid)
  • Depakine
  • Lidocaine
  • Phenobarbital Sodium
  • Ethosuximide
  • Calcichew (1 Df=500mg/400ie ?chewing Tablet)
  • Plaquenil Sulfate
  • Alendronic Acid


Lipodystrophy Acquired, Injection Site Reaction
Patient was taking Kenacort Inj. Patient felt the following Kenacort side effects: lipodystrophy acquired, injection site reaction on Dec 20, 2013 from FR Additional patient health information: Female , 57 years of age, . Kenacort Inj dosage: N/A.

Optic Neuritis
Adverse event was reported on Dec 18, 2013 by a Male taking Kenacort-a Inj (Dosage: Intravitreal Injection) was diagnosed with and. Location: JP , 50 years of age, After Kenacort was administered, patient encountered several Kenacort side effects: optic neuritis. Patient was hospitalized.

Overdose, Cushing^s Syndrome
on Dec 17, 2013 Patient from IT , 37 years of age, was treated with Kenacort. Directly after, patient experienced the unwanted or unexpected Kenacort side effects: overdose, cushing^s syndrome. Kenacort dosage: Formu:40mg/ml.


Hypoglycaemic Unconsciousness, Hypoglycaemia, Hyperglycaemia
on Dec 13, 2013 Female from NL , 43 years of age, weighting 211.6 lb, was diagnosed with and was treated with Kenacort-a40 Inj. Patient felt the following Kenacort side effects: hypoglycaemic unconsciousness, hypoglycaemia, hyperglycaemia. Kenacort-a40 Inj dosage: Suspension 40mg/ml 1ml Flask.
Multiple prescriptions taken:
  • Humalog (Injection Fluid 100e/ml 10ml Flask)


Csf Pressure Decreased, Headache, Paraesthesia
Patient was taking Kenacort Inj 40 Mg/ml. After Kenacort was administered, patient encountered several Kenacort side effects: csf pressure decreased, headache, paraesthesia on Feb 03, 2014 from IT Additional patient health information: Male , 36 years of age, . Kenacort Inj 40 Mg/ml dosage: 1df=40 Mg/ml Inj Sol?1-unit/total.
Multiple concurrent drugs taken:
  • Lidocaine Hcl (1df=1-unit/total)
Patient was hospitalized.

Cushing^s Syndrome
Adverse event was reported on Dec 13, 2013 by a Female taking Kenacort-a (Dosage: N/A) . Location: IT , 37 years of age, Directly after, patient experienced the unwanted or unexpected Kenacort side effects: cushing^s syndrome.

Diverticulitis, Retinal Pigment Epitheliopathy, Systolic Hypertension
on Dec 17, 2013 Female from FR , 49 years of age, was diagnosed with and was treated with Kenacort Inj. Patient felt the following Kenacort side effects: diverticulitis, retinal pigment epitheliopathy, systolic hypertension. Kenacort Inj dosage: N/A.
Multiple prescriptions taken:
  • Azactam For Inj 1 Gm (Last Dose: 19sep2013)
  • Metronidazole (Last Dose: 19sep2013)
Patient was hospitalized.

Oesophageal Perforation
on Dec 10, 2013 Male from JP , 55 years of age, was diagnosed with and was treated with Kenacort-a Inj. After Kenacort was administered, patient encountered several Kenacort side effects: oesophageal perforation. Kenacort-a Inj dosage: N/A.

Oesophageal Perforation
Patient was taking Kenacort-a Inj. Directly after, patient experienced the unwanted or unexpected Kenacort side effects: oesophageal perforation on Dec 10, 2013 from JP Additional patient health information: Male , 67 years of age, was diagnosed with and. Kenacort-a Inj dosage: Kenacort-a Inj.

Retinal Detachment
Adverse event was reported on Nov 25, 2013 by a Male taking Kenacort-a Inj (Dosage: Subcapsular Injection) was diagnosed with and. Location: JP , 40 years of age, Patient felt the following Kenacort side effects: retinal detachment.

Oesophageal Perforation, Pneumomediastinum, Paraoesophageal Abscess
on Nov 06, 2013 Male from JP , 60 years of age, was treated with Kenacort-a Inj 40 Mg/ml. After Kenacort was administered, patient encountered several Kenacort side effects: oesophageal perforation, pneumomediastinum, paraoesophageal abscess. Kenacort-a Inj 40 Mg/ml dosage: 1ml:10mg Of 40mg/5ml,injected In To Submucosa. Patient was hospitalized.

Nerve Injury, Neuralgia, Paralysis
on Oct 29, 2013 Male from NL , 58 years of age, weighting 176.4 lb, was diagnosed with and was treated with Kenacort. Directly after, patient experienced the unwanted or unexpected Kenacort side effects: nerve injury, neuralgia, paralysis. Kenacort dosage: 21-aug-2013.
Associated medications used:
  • Diclofenac Potassium Tabs 50 Mg
  • Paracetamol Tabs 500 Mg (1 Df: 2 Tabs)


Cerebral Haemorrhage
Patient was taking Kenacort-a Inj 10 Mg/ml. Patient felt the following Kenacort side effects: cerebral haemorrhage on Sep 24, 2013 from NL Additional patient health information: Male , 77 years of age, . Kenacort-a Inj 10 Mg/ml dosage: N/A.
Multiple prescriptions taken:
  • Acenocoumarol
Patient was hospitalized.

Cubital Tunnel Syndrome
Adverse event was reported on Aug 12, 2013 by a Male taking Kenacort-a Inj (Dosage: N/A) was diagnosed with and. Location: JP , 63 years of age, After Kenacort was administered, patient encountered several Kenacort side effects: cubital tunnel syndrome.

Cubital Tunnel Syndrome
on Aug 12, 2013 Male from JP , 40 years of age, was diagnosed with and was treated with Kenacort-a Inj. Directly after, patient experienced the unwanted or unexpected Kenacort side effects: cubital tunnel syndrome. Kenacort-a Inj dosage: N/A.

Articular Calcification
on Aug 07, 2013 Female from JP , 51 years of age, was diagnosed with and was treated with Kenacort-a Inj. Patient felt the following Kenacort side effects: articular calcification. Kenacort-a Inj dosage: No Of Inj:22.
Multiple prescriptions taken:
  • Methotrexate
  • Abatacept


Articular Calcification
Patient was taking Kenacort-a Inj. After Kenacort was administered, patient encountered several Kenacort side effects: articular calcification on Aug 07, 2013 from JP Additional patient health information: Female , 58 years of age, was diagnosed with and. Kenacort-a Inj dosage: No Of Inj:22.
Multiple concurrent drugs taken:
  • Methotrexate
  • Infliximab
  • Prednisone


Cytomegalovirus Chorioretinitis, Hypopyon
Adverse event was reported on Jul 17, 2013 by a Male taking Kenacort-a Inj (Dosage: Intraocular(vitreous Injection) On 05sep07: 4mg?intraocular(sub-tennon) On 10sep07: 12mg) was diagnosed with and. Location: JP , 75 years of age, Directly after, patient experienced the unwanted or unexpected Kenacort side effects: cytomegalovirus chorioretinitis, hypopyon.
Associated medications used:
  • Cravit
  • Diclod
  • Flumetholon
Patient was hospitalized.

Tenosynovitis
on Apr 19, 2013 Male from JP , 52 years of age, was treated with Kenacort Inj 10 Mg/ml. Patient felt the following Kenacort side effects: tenosynovitis. Kenacort Inj 10 Mg/ml dosage: N/A.

Suppressed Lactation
on Sep 20, 2012 Female from AU , 35 years of age, was diagnosed with and was treated with Kenacort. After Kenacort was administered, patient encountered several Kenacort side effects: suppressed lactation. Kenacort dosage: 1df:80-120mg (total Dose). Injection..

Injection Site Atrophy, Muscle Atrophy
Patient was taking Kenacort Retard 80 Inj. Directly after, patient experienced the unwanted or unexpected Kenacort side effects: injection site atrophy, muscle atrophy on Sep 18, 2012 from FR Additional patient health information: Female , 61 years of age, . Kenacort Retard 80 Inj dosage: N/A.

Anaphylactic Shock, Urticaria, Gamma-glutamyltransferase Decreased
Adverse event was reported on Sep 12, 2012 by a Female taking Kenacort (Dosage: Route:intra Tendon Inj) was diagnosed with and. Location: JP , 70 years of age, weighting 132.3 lb, Patient felt the following Kenacort side effects: anaphylactic shock, urticaria, gamma-glutamyltransferase decreased.
Multiple prescriptions taken:
  • Xylocaine (Route:intra Tendon Inj)
  • Ursodeoxycholic Acid (Tab)
  • Atenolol Tabs
  • Unisia (1df=8mg + 5mg)
  • Crestor (Tab)
Patient was hospitalized.

Blood Cortisol Decreased, Diabetes Mellitus, Hypertension, Hyperglycaemia, Cushingoid, Cushing's Syndrome
on May 30, 2012 Female from SWITZERLAND , 39 years of age, weighting 198.4 lb, was diagnosed with and was treated with Kenacort-a Ophthalmic Ointment. After Kenacort was administered, patient encountered several Kenacort side effects: blood cortisol decreased, diabetes mellitus, hypertension, hyperglycaemia, cushingoid, cushing's syndrome. Kenacort-a Ophthalmic Ointment dosage: One Single Administration.
Multiple concurrent drugs taken:
  • Calcimagon-d3
  • Norvir
  • Prezista
  • Truvada
  • Rasilez


Retinal Artery Occlusion, Anaphylactoid Reaction
on May 10, 2012 Female from JAPAN , 51 years of age, weighting 119.0 lb, was diagnosed with and was treated with Kenacort. Directly after, patient experienced the unwanted or unexpected Kenacort side effects: retinal artery occlusion, anaphylactoid reaction. Kenacort dosage: 1df= 40 Mg/1 Ml. Patient was hospitalized.

1 of 8 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Kenacort Side Effects

    Did You Have a Kenacort Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Kenacort for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective